Business Description
Diaceutics PLC
ISIN : GB00BJQTGV64
Description
Diaceutics PLC is a data analytics and implementation services company that services the pharmaceutical industry. It provides the pharma and biotech companies with an end-to-end commercialization solution for the launch of precision medicine, enabled by DXRX The Diagnostic Network. DXRX is the diagnostic commercialization platform designed specifically for precision medicine, integrating multiple pipelines of real-world, real-time diagnostic testing data from a network of labs. These solutions are helping the pharma companies commercialize their precision medicines, enhance their return on investment and ultimately improve patients' lives.
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 13.83 | |||||
Equity-to-Asset | 0.88 | |||||
Debt-to-Equity | 0.03 | |||||
Debt-to-EBITDA | 0.5 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 12.93 | |||||
Beneish M-Score | -2.65 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 19.9 | |||||
3-Year EBITDA Growth Rate | 143.8 | |||||
3-Year FCF Growth Rate | 18.6 | |||||
3-Year Book Growth Rate | 0.3 | |||||
Future 3-5Y Total Revenue Growth Rate | 26.37 |
Momentum Rank
10/10
Name | Current | Vs Industry | Vs History |
---|
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 6.4 | |||||
Quick Ratio | 6.4 | |||||
Cash Ratio | 3.8 | |||||
Days Sales Outstanding | 92 | |||||
Days Payable | 64.32 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.1 | |||||
Shareholder Yield % | 0.17 |
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 83.15 | |||||
Operating Margin % | -12.74 | |||||
Net Margin % | -7.37 | |||||
FCF Margin % | -14.95 | |||||
ROE % | -4.21 | |||||
ROA % | -3.72 | |||||
ROIC % | -7.83 | |||||
ROC (Joel Greenblatt) % | -39.14 | |||||
ROCE % | -5.51 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 4.68 | |||||
PB Ratio | 2.69 | |||||
Price-to-Tangible-Book | 4.27 | |||||
Price-to-Operating-Cash-Flow | 86.67 | |||||
EV-to-EBIT | -39.77 | |||||
EV-to-Forward-EBIT | 35.06 | |||||
EV-to-EBITDA | 39.29 | |||||
EV-to-Revenue | 3.98 | |||||
EV-to-Forward-Revenue | 1.87 | |||||
EV-to-FCF | -26.62 | |||||
Price-to-Net-Current-Asset-Value | 4.88 | |||||
Price-to-Net-Cash | 9.77 | |||||
Earnings Yield (Greenblatt) % | -2.51 | |||||
FCF Yield % | -3.23 | |||||
Forward Rate of Return (Yacktman) % | 13.82 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:DIUXF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Diaceutics PLC Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 29.967 | ||
EPS (TTM) ($) | -0.026 | ||
Beta | 0 | ||
Volatility % | 30.21 | ||
14-Day RSI | 0 | ||
14-Day ATR ($) | 0 | ||
20-Day SMA ($) | 1.3672 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range ($) | 1.3672 - 1.3672 | ||
Shares Outstanding (Mil) | 84.46 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Diaceutics PLC Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Diaceutics PLC Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Diaceutics PLC Frequently Asked Questions
What is Diaceutics PLC(DIUXF)'s stock price today?
The current price of DIUXF is $1.37. The 52 week high of DIUXF is $1.37 and 52 week low is $1.37.
When is next earnings date of Diaceutics PLC(DIUXF)?
The next earnings date of Diaceutics PLC(DIUXF) is 2024-09-26 Est..
Does Diaceutics PLC(DIUXF) pay dividends? If so, how much?
Diaceutics PLC(DIUXF) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |